|
advertisement
|
Company Overview: |
| Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively. |
Products and Services: |
| Medivation's current product pipeline consists of small-molecule drugs in development to treat three large, unmet medical needs—Alzheimer’s disease, Huntington’s disease and hormone-refractory prostate cancer. |
|
|
|
|
Back to Top
|
|
Working @ Medivation
Have your shout about working or interveiwing at Medivation
1 message posted
Message Posted:
Working @ Medivation
Share your experiences about working, interviewing or applying for a job at ...
Author: Obi Posted: 4/2/2007 3:08:47 PM |
View or add comments about Medivation
Back to Top
|
Medivation in the News
- Medivation Added to Russell 2000 Index (PR Newswire)
Published: Wednesday, July 11, 2007
- Medivation Added to Russell 2000 Index
Published: Wednesday, July 11, 2007
- Medivation Names Sarvajit Chakravarty, Ph.D. Vice President of Medicinal Chemistry (PR Newswire)
Published: Monday, July 09, 2007
- Biotech firm's stock jumps on Alzheimer's data - Medivation's Dimebon helped patients in small, one-year trials
Published: Tuesday, June 12, 2007
- Biotech firm's stock jumps on Alzheimer's data / Medivation's Dimebon helped patients in small, one-year trials
Published: Tuesday, June 12, 2007
View more news about Medivation
Back To Top |
|
|
|
|
Categories:
|
Biotechnology
|
|
Back to Top
|
|
|
|